Article
Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomes.
Clinical pharmacokinetics - 1 Apr 1997
Masson E, Zamboni W C
Abstract excerpt
Cancer chemotherapy doses are empirical in that the majority are administered at a fixed dose (mg/m2 or mg/kg). One reason for this is the intrinsic sensitivity of the tumour or host cells to one particular chemotherapy agent is unknown. Therefore, the likelihood of response or toxicity is unpredictable a priori. This contrasts with antimicrobial chemotherapy where sensitivity (minimum inhibitory concentration)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
